Tag: biomedical
-
Shake Off Your Fear of Doctors
This post explores some of the best ways to get yourself on solid ground when it comes to the medical side of your life.
-
BASF Licensing Precise Crispr Editing from Broad Institute
The global chemical company BASF is licensing a more precise form of genome editing from the Broad Institute, a genetics research center affiliated with Harvard University and MIT.
-
NVIDIA, Scripps Partner on Medical Deep Learning Applications
A high-performance computer chip maker and life science research center are collaborating on extending deep learning, a form of artificial intelligence, into more areas of medical science and practice.
-
Genome Editing, Informatics Lead to New Antibiotic
Researchers in the U.K. created an antibiotic acid from a natural microbe found in soil, using a combination of the genome editing technique Crispr and bioinformatics.
-
Licensing Deal for Bioinks in 3-D Printed Transplant Lungs
A company in Maryland developing alternatives to human organ transplants is licensing a technology to help create 3-D printed lungs for transplantation with bioinks derived from tobacco plants.
-
Nerve Stimulation Reduces Pain, Fatigue from Lupus
Results from a clinical trial show external stimulation of a major nerve in the body helps relieve pan and fatigue in people with systemic lupus erythematosus, more commonly known as lupus.
-
Health System Connects Mobile App to 250 Devices
A health care system in Boston is developing a mobile app to make it easier to share data from 250 home and wearable devices that collect medically related information.
-
NIH Supporting Electronic Neuro Drug Test Technology
A university spin-off enterprise is receiving funds from National Institute of Mental Health to develop a simple, reliable electronic device to evaluate effects of neurological drugs on brain cells.
-
Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments
Drug maker AbbVie and biotechnology company Morphic Therapeutic are collaborating on new treatments for fibrosis based on Morphic’s technology blocking proteins that promote fibrosis.
-
Diabetes Drug Assessed Long-Term Against All Other Treatments
A new clinical trial is testing the drug semaglutide for people with type 2 diabetes against as many as 40 other diabetes treatments when used as a supplemental drug over 2 years.